Dr. Ge Yunjun, a lecturer at the School of Medicine, Jiangnan University, specializes in G protein-coupled receptor (GPCR) and tumor pharmacology research. He is a recipient of the National Natural Science Foundation of China's Youth Science Fund. Dr. Ge obtained his Bachelor's degree in Biomedical Engineering from Huazhong University of Science and Technology in 2009, his Master's degree in Pharmacy from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences in 2015, and his Ph.D. in Biomedical Sciences from the University of Macau in 2020. From 2020 to 2022, he conducted postdoctoral research at the Chinese University of Hong Kong (Shenzhen) with a research station at the University of Science and Technology of China. Prior to joining Jiangnan University in 2022, he worked in pharmaceutical research at relevant companies in 2009 and 2015. Dr. Ge's research experience includes high-throughput drug screening, GPCR molecular conformation and signal transduction studies, analysis of the pharmacological effects of biased and allosteric modulators, molecular cloning, and protein expression and purification. His current research focuses on exploring tumor-promoting and anti-tumor signaling pathways in breast and prostate cancer, developing biased modulators, and analyzing the combined effects of active components of anti-tumor traditional Chinese medicine (TCM). He also investigates the multi-target analysis and anti-tumor mechanisms of single active molecules in TCM. Dr. Ge has published over ten scientific papers in prestigious journals such as FASEB Journal (2020), Nature Communications (2020; 2022), Signal Transduction and Targeted Therapy (2020), Pharmacological Research (2020), and Acta Pharmacologica Sinica (2014; 2020). |
